# A Study of Intranasal Live Attenuated Influenza Vaccine Immunogenicity and Associations With the Nasopharyngeal Microbiome Among Children in the Gambia

> **NCT02972957** · PHASE4 · COMPLETED · sponsor: **London School of Hygiene and Tropical Medicine** · enrollment: 364 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Nasovac-S
- **DRUG:** Azithromycin

## Key facts

- **NCT ID:** NCT02972957
- **Lead sponsor:** London School of Hygiene and Tropical Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-30
- **Primary completion:** 2018-12-19
- **Final completion:** 2019-05-23
- **Target enrollment:** 364 (ACTUAL)
- **Last updated:** 2020-02-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02972957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02972957, "A Study of Intranasal Live Attenuated Influenza Vaccine Immunogenicity and Associations With the Nasopharyngeal Microbiome Among Children in the Gambia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02972957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*